InsiderTrades.com logo
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

RENE Insider Trading

Insider Ownership Percentage: 20.33%
Insider Buying (Last 12 Months): £16,709.88
Insider Selling (Last 12 Months): GBX 0

ReNeuron Group Insider Trading History Chart

This chart shows the insider buying and selling history at ReNeuron Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReNeuron Group Share Price & Price History

Current Price: GBX 3.38
Price Change: ▼ Price Decrease of -0.075 (-2.17%)
As of 02/5/2024 03:22 PM ET

This chart shows the closing price history over time for RENE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

ReNeuron Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/12/2023John HawkinsInsiderBuy52,332GBX 9£4,709.88
6/16/2023Iain G RossInsiderBuy150,000GBX 8£12,000
4/6/2023Barbara StaehelinInsiderBuy50,000GBX 9£4,500
3/3/2023John HawkinsInsiderBuy47,668GBX 10£4,766.80
2/24/2023Barbara StaehelinInsiderBuy30,000GBX 10£3,000
1/23/2023Iain G RossInsiderBuy100,000GBX 10£10,000
9/2/2022Iain G RossInsiderBuy30,000GBX 26£7,800
7/12/2022Barbara StaehelinInsiderBuy127,000GBX 30£38,100
10/20/2021Barbara StaehelinInsiderBuy43,000GBX 115£49,450
See Full Table
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

SEC Filings (Institutional Ownership Changes) for ReNeuron Group (LON:RENE)

21.40% of ReNeuron Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ReNeuron Group logo
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Read More on ReNeuron Group

Today's Range

Now: GBX 3.38
Low: 3.28
High: 3.50

50 Day Range

MA: GBX 3.38
Low: 3.38
High: 3.45

52 Week Range

Now: GBX 3.38
Low: 3.28
High: 11.50

Volume

177,373 shs

Average Volume

578,249 shs

Market Capitalization

£1.93 million

P/E Ratio

N/A

Dividend Yield

0.76%

Beta

0.69

Who are the company insiders with the largest holdings of ReNeuron Group?

ReNeuron Group's top insider investors include:
  1. Barbara Staehelin (Insider)
  2. Iain G Ross (Insider)
  3. John Hawkins (Insider)
Learn More about top insider investors at ReNeuron Group.
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story